Clinical Analytics Market worth $81.32 billion by 2030 with 19.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 29, 2025 /PRNewswire/ -- The global Clinical Analytics Market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2025 to 2030, culminating in a forecasted valuation of US$81.32 billion by the end of the period. The growth of the clinical analytics market is primarily driven by the shift toward value-based care and reimbursement models, pushing healthcare organizations to enhance outcomes while reducing costs. Increasing regulatory openness to real-world evidence (RWE) is fostering the integration of advanced analytics into clinical and research workflows. Additionally, the rapid adoption of cloud-based and modern data platforms, enabling scalable, real-time insights and seamless interoperability, further accelerates market expansion.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21358684
Browse in-depth TOC on " Clinical Analytics Market "
400 - Tables
50 - Figures
400 - Pages
By use case, the healthcare use case segment accounted for significant growth in the clinical analytics market in 2024, driven by the increasing adoption of value-based care models and the growing demand for data-driven decision-making to improve patient outcomes. Healthcare providers are leveraging clinical analytics for clinical decision support, population health management, remote patient monitoring, and operational efficiency enhancement. The rising prevalence of chronic diseases, aging populations, and higher patient volumes are further accelerating the need for advanced analytics to predict disease trends, optimize resource allocation, and reduce readmissions and healthcare costs. Additionally, the integration of analytics with EHR systems, AI, and telehealth platforms is enabling real-time insights, personalized care plans, and improved quality reporting, reinforcing the segment's strong growth trajectory.
By end users, A key driver for the significant growth of the healthcare providers segment in the clinical analytics market is the increasing need to improve patient outcomes, reduce costs, and optimize operational efficiency through real-time, data-driven decision-making. Healthcare providers generate the majority of clinical data from EHRs, diagnostic imaging, laboratory systems, and connected medical devices, creating a strong foundation for analytics adoption. As value-based care models gain traction globally, providers are under growing pressure to demonstrate measurable improvements in quality of care and operational performance. This growth is fueled using predictive analytics to identify high-risk patients, optimize resource allocation, and support proactive interventions that reduce readmission rates and complications. Moreover, real-time insights enable hospitals and health systems to streamline workflows, reduce waste, and enhance care coordination, making clinical analytics an indispensable tool in modern healthcare delivery.
By geography, North America dominated the clinical analytics market in 2024, driven by its highly digitized healthcare ecosystem, significant investments in healthcare IT infrastructure, and the widespread adoption of electronic health records (EHRs). The United States, in particular, benefits from a strong regulatory framework promoting data-driven care models and value-based reimbursement programs, encouraging healthcare providers and payers to leverage advanced analytics for improving outcomes and reducing costs. A mature network of health IT vendors, academic research centers, and pharmaceutical companies has further accelerated innovation in areas such as precision medicine, population health management, and clinical decision support. Rising chronic disease prevalence, coupled with the growing demand for real-world evidence (RWE) and digitized clinical trials, has fuelled analytics adoption across hospitals, payer networks, and life sciences organizations, solidifying North America's position as the global leader in the clinical analytics market.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=21358684
The report profiles key players such Optum, Inc. (UnitedHealth Group) (US), Merative (US), Epic Systems Corporation (US), GE HealthCare (US), Siemens Healthineers (Germany), Oracle Health Sciences (US), McKesson Corporation (US), Veradigm LLC (US), IQVIA (US), Cotiviti Inc. (US), Health Catalyst (US), Cognizant (US), Koninklijke Philips N.V. (Netherlands), Dassault Systèmes (France), Athenahealth, Inc. (US), Veeva Systems (US), ICON plc (Ireland), eClinicalWorks (US), Accenture (Ireland), CVS Health (US), Inovalon (US), WNS (Holdings) Ltd. (UK), SOPHiA GENETICS (Switzerland), F. Hoffmann-La Roche Ltd (Roche)(FLATIRON HEALTH) (US), SAS Institute, Inc. (US).
Optum Inc:
Optum Inc is a leading provider of healthcare data and analytics solutions, leveraging its extensive real-world data assets and AI-driven platforms to deliver insights across payers, providers, and life sciences organizations. Through its Optum Insight division, the company integrates clinical, claims, and genomic data to support value-based care, predictive analytics, and real-world evidence generation. Optum's strategic acquisitions, including Change Healthcare, have strengthened its data interoperability and analytics capabilities, enabling seamless integration across the healthcare ecosystem. Its vertically integrated structure—spanning care delivery, insurance, and analytics—positions Optum as a comprehensive player in the clinical analytics market, offering scalable, data-driven solutions for improving outcomes, optimizing workflows, and advancing evidence-based decision-making.
IQVIA
IQVIA is a global leader in clinical data and advanced analytics, providing AI-powered platforms that streamline clinical trial operations and data management. Its Clinical Data Analytics Suite (CDAS) enables real-time data integration, visualization, and predictive modeling across structured and unstructured sources, helping sponsors and CROs accelerate study timelines and enhance oversight. IQVIA's deep domain expertise in clinical research, combined with its vast global data network, supports analytics for trial design, site selection, and patient recruitment. With a focus on automation, efficiency, and regulatory compliance, IQVIA remains a key innovator in clinical analytics, driving digital transformation across the life sciences value chain.
Oracle
Oracle has emerged as a major force in healthcare and life sciences analytics through its cloud-based infrastructure and integrated data intelligence platforms. Following its acquisition of Cerner, Oracle expanded its reach into clinical and EHR data management, enabling end-to-end analytics across research, care delivery, and population health. Its Oracle Analytics Intelligence for Life Sciences and Clinical Development Analytics solutions leverage AI and machine learning to unify data, ensure compliance, and accelerate clinical insights. With strong capabilities in data integration, scalability, and value-based health analytics, Oracle offers a robust ecosystem for organizations seeking enterprise-grade clinical analytics solutions built on secure and interoperable cloud architecture.
For more information, Inquire Now!
Related Reports:
Precision Diagnostics & Medicine Market
Remote Patient Monitoring Market
Population Health Management Market
Get access to the latest updates on Clinical Analytics Companies and Clinical Analytics Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article